ESR1 and neoplasm: Alterations occur most frequently in hormone receptor status and Ki67 labeling index, and these changes usually carry a worse prognosis: for example, an estrogen receptor (ER) positive tumor may become negative, and the Ki67 index may increase during the progression of the disease.